Načítá se...

Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease: a review

BACKGROUND: Cholinesterase inhibitors have all been available in oral formulations, but a rivastigmine transdermal patch has now been developed and is approved in many countries worldwide for the treatment of mild-to-moderate Alzheimer’s disease (AD) (including the USA, Latin America, Europe and Asi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kurz, A, Farlow, M, Lefèvre, G
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2009
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2734925/
https://ncbi.nlm.nih.gov/pubmed/19392927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1742-1241.2009.02052.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!